Mpox vaccination in Ontario: clinical, community, and research perspectives

The 2022 outbreak of mpox in Canada disproportionately affected gay, bisexual, and other men who have sex with men (GBMSM). Recognizing that the GBMSM group is at high risk of exposure, Ontario deployed the two-regimen modified vaccinia ankara–bavaria nordic (MVA-BN) vaccine, first in June 2022 and next in September 2022. Vaccine uptake, however, has remained low, especially for the second dose, despite increases in cases and continuing transmission.

This Centre for Vaccine Preventable Diseases (CVPD) webinar will be moderated by CVPD associate director and EPIC member Jeff Kwong, who will be joined by fellow EPIC member, Darrell Tan, along with Ramandip Grewal, Devan Nambiar and Mac Stewart for a discussion on the clinical aspects of mpox, perspectives from the community, and findings on how to reach those at risk to help increase vaccine coverage.

Date and time: February 25th, 12:00 – 1:30 PM

Location: Virtual

Register here via CVPD!